Detalhe da pesquisa
1.
Quantitative analysis of the three gut microbiota in UC and non-UC patients using real-time PCR.
Microb Pathog
; 181: 106198, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295481
2.
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
Dig Dis Sci
; 68(6): 2635-2646, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119375
3.
Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial.
Eur Heart J
; 43(21): 2023-2033, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35048107
4.
Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis.
J Res Med Sci
; 27: 54, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36092483
5.
Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
Am J Gastroenterol
; 116(8): 1667-1675, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33767101
6.
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
J Antimicrob Chemother
; 76(3): 753-757, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338232
7.
Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis.
J Antimicrob Chemother
; 76(2): 286-291, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33063117
8.
Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial.
Nutr J
; 20(1): 35, 2021 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33838673
9.
Changes in liver fibrosis in patients with chronic hepatitis C after successful direct-acting antiviral therapy.
Int J Clin Pract
; 75(6): e14145, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709413
10.
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus.
Int J Clin Pract
; 75(8): e14304, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930223
11.
Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).
J Clin Lab Anal
; 35(5): e23768, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769591
12.
SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial.
Clin Infect Dis
; 70(10): 2206-2212, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504303
13.
A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.
Int J Cancer
; 146(1): 18-25, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30891750
14.
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.
Lancet
; 394(10199): 672-683, 2019 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31448738
15.
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
J Antimicrob Chemother
; 75(11): 3373-3378, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812025
16.
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
J Antimicrob Chemother
; 75(11): 3379-3385, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812039
17.
The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment.
J Gastroenterol Hepatol
; 35(9): 1590-1594, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31994788
18.
A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting.
Harm Reduct J
; 17(1): 56, 2020 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32795371
19.
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.
Harm Reduct J
; 17(1): 80, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081794
20.
MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma.
J Cell Biochem
; 120(4): 5010-5017, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30260046